<p>OpenAI has acquired Orchestra Bio, a startup building AI agents to help pharmaceutical companies manage drug development, the ChatGPT maker shared exclusively with Axios. Why it matters: Rival AI giants OpenAI and Anthropic are both pushing into science as they look to expand beyond their core compe</p>